Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
British Journal of Pain|September 14, 2020
Successful and unsuccessful recruitment and retainment strategies in a UK multicentre drug trial for a rare chronic pain condition which performed above targetJatinder Bisla, Gareth Ambler, Bernhard Frank, et al.Pain|May 28, 2013
Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: results from a cross-sectional general population studyNicola J Goodson, Blair H Smith, Lynne J Hocking, et al.Pain|May 23, 2025
Postacute COVID-19 syndrome and fibromyalgia syndrome are associated with anti-satellite glial cell IgG serum autoantibodies but only fibromyalgia syndrome serum-IgG is pronociceptiveRichard J Berwick, Peyman Sahbaie, Grace Kenny, et al.The Lancet. Neurology|April 17, 2024
Complex regional pain syndrome: advances in epidemiology, pathophysiology, diagnosis, and treatmentMichael C Ferraro, Neil E O'Connell, Claudia Sommer, et al.Neuromodulation : Journal of the International Neuromodulation Society|September 27, 2014
The use of 10-kilohertz spinal cord stimulation in a cohort of patients with chronic neuropathic limb pain refractory to medical managementAdnan Al-Kaisy, Stefano Palmisani, Tom Smith, et al.Pain|September 25, 2014
Longstanding complex regional pain syndrome is associated with activating autoantibodies against alpha-1a adrenoceptorsEric Dubuis, Victoria Thompson, Maria Isabella Leite, et al.Pain|August 25, 2022
Delphi study to define core clinical outcomes for inclusion in a complex regional pain syndrome international research registry and data bankAlison Llewellyn, Lisa Buckle, Sharon Grieve, et al.Journal of Translational Medicine|November 7, 2021
Mechanistically informed non-invasive peripheral nerve stimulation for peripheral neuropathic pain: a randomised double-blind sham-controlled trialSelina Johnson, Anne Marshall, Dyfrig Hughes, et al.Pain|August 6, 2011
Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndromeDanielle Kohr, Pratibha Singh, Marlene Tschernatsch, et al.Trials|October 26, 2014
Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trialAndreas Goebel, Nicholas Shenker, Nick Padfield, et al.Pageof 13